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We found that a strains of Yersinia pestis (KIM5) which lacked the nhaA 
gene was fully attenuated in a plague model. This gene produces a protein 
of the sodium-proton antiporter family which expel sodium ions from the 
bacterial cytoplasm in exchange for hydrogen ions, or protons, from the 
surrounding environment. A Y. pestis strain that contained the nhaA 
mutation showed a significant decrease in its ability to survive in both 
sheep’s blood and serum. Decreased growth rates were also observed 
when the nhaA deficient strain was tested in the artificial serum media Opti-
MEM® when compared to the wild type strain. A similar growth phenotype 
was observed when wild type and nhaA mutant strains were tested in LB 
media set to mimic pH and salt conditions of blood. These observations 
indicate that sodium-proton antiport activity of Y. pestis is essential for the 
survival of the bacterium in certain environments, such as the blood of an 
infected host. 2-aminopyrimidine was used to inhibit NhaA activity, and 
when tested in Opti-MEM®, bacterial growth rates decreased. These 
findings lead us to propose that sodium-proton antiporter inhibition is a 
novel way of treating bacterial blood-borne diseases. 
Figure 2) Effects of sodium pump mutations on Y. pestis virulence in a 
murine bubonic plague model. 
Abstract 
Figure 4) Y. pestis strains grown in Opti-MEM® artificial serum media. 
Figure 6) Activity of the NhaA protein of Y. pestis in the presence of 2-
aminopyrimidine (2-AP). 
Figure 3) Survival of  Y. pestis in sheep’s blood (A) and sheep’s serum (B). 
Figure 5) Wild type and nhaA mutant growth in 
140 mM KCl and NaCl LB media. 
Background 
Yersinia pestis is a pathogenic bacterium that causes the fatal disease 
bubonic plague. Further development of the disease can lead to 
septicemia or pneumonic plague. During the middle ages this disease 
was known as “The Black Death” for the necrosis of tissue that occurred 
during infection. It was responsible for killing over one quarter of the 
people living in Europe during that time period. Through medical 
advances and the discovery of antibiotics, treatment of plague has 
become relatively safe and successful when combined with proper and 
quick diagnosis. However, due to its high infectivity and lethality, Y. pestis 
has also recently become considered a potential bioterrorism agent.  
This particular pathogen is a blood-borne disease and is transmitted to a 
host via a flea or by an already infected animal. The sodium levels that 
occur naturally in the blood of animals can cause a fatal shift in the 
amount of sodium in the cell for Y. pestis.Y. pestis, as well as other 
pathogens, protect cells from sodium toxicity by expelling sodium from 
their cytoplasm. There are two types of sodium pumps, primary and 
secondary. NADH quinone reductase (NQR) is a primary pump while the 
secondary pumps are called NhaA and NhaC. The roles of sodium pumps 
are to not only prevent the intracellular sodium levels to become toxic, but 
also to generate a gradients so that the sodium motive force (SMF) can 
continue. Much like the the proton motive force (PMF) the SMF is 
controlled by the amount of sodium inside and outside of a given cell. 
It is this role of these secondary sodium pumps that are the focus of this 
investigation to whether or not sodium/proton antiporters are essential for 
the virulence of Y. pestis in a host.  
Figure 1) The sodium dependent cycle in Y. pestis (A) and predicted sodium dependent 
systems (B). 
Conclusions 
•The nhaA gene is essential for virulence of Y. pestis, likely due to 
the fact that without it, bacterial growth in blood or serum is hindered. 
 
•Death occurs due to the levels of sodium that occur naturally in the 
blood, 140 mM. Without the NhaA protein the levels become toxic to  
the cell and it quickly dies.  
 
•Inhibiting the NhaA protein with 2-aminopyrimidine shows a growth 
defect in the wild type strain in Opti-MEM® similar to that of the nhaA 
deletion. 
 
•We hypothesize that the inability to grow due to the salinity of the 
blood of a host would allow for the host’s immune system to clear the 
infection before it becomes too overwhelming for the body to deal 
with.  
The nqr deletion mutant strain(Dnqr) produced around the same survival rate in mice as did the wild type strain (wt). Whereas  
the nhaA deletion mutant strain (DnhaA) showed survival in all of the test subjects. The nhaA gene was cloned into the 
plasmid pWSK130 and electroporated into the ΔnhaA strain for complementation purposes. When this strain (DnhaA-comp) was tested in mice 
, death still ensued for some of the animals, but survival rates were still 
higher than those from the Δnqr  and wild type strains. 
Genome sequence analyses revealed that Y. pestits has two types of sodium efflux pumps, primary sodium pump, NQR, and secondary 
sodium pumps and  multiple sodium dependent transporters.  
140 mM is the average concentration for sodium levels in the blood 
of humans, as well as most other animals (1). Wild type and nhaA  
deficient strains were tested in LB media containing 140 mM sodium or 
potassium. A defect was only seen in the nhaA mutant in the sodium  
LB media and not potassium.  
The wild type (WT), nqr (Dnqr) and nhaA (DnhaA) mutants, and the pWSK130nhaA complemented strain (DnhaA-comp) were 
tested in both sheep’s blood andsheep’s serum to measure growth. After incubation, cultures were diluted and plated so that colony 
forming units (CFU) couldbe counted to make a quantitative assessment of the survival that occurred. Again a major defect is seen 
in the nhaA mutant, but not in the wild type or the nqr mutant, and the defect is corrected upon complementing the nhaA  mutant 
strain with the nhaA-encoded plasmid. 
The wild type, ΔnhaA, and ΔnhaA+pWSK130nhaA strains were tested in Opti-MEM®. Almost no  
growth was observed when nhaA was deleted, but when complemented to the pWSK130nhaA plasmid,  
full growth was seen in the Opti-MEM®.  
2-aminopyrimidine (2-AP) is a chemical that inhibits the activity of the NhaA protein. As the amount of 2-AP in 
solution increased, the activity of the NhaA protein decreased (A, B). Different concentrations of 2-AP were added 
to Opti-MEM® artificial serum media and inoculated with Y. pestis. Increasing concentrations of 2-AP decreased the 
growth rates of the bacteria.  
A)  B) 
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